Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis
Open Access
- 1 April 2016
- journal article
- Published by Elsevier in Journal of Traditional and Complementary Medicine
- Vol. 6 (2) , 160-167
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic SteatohepatitisGastroenterology, 2008
- Risk factors and mechanisms of non-alcoholic steatohepatitisPathophysiology, 2008
- Yo Jyo Hen Shi Ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob/ob mice fed a high fat or methionine–choline‐deficient dietLiver International, 2007
- EFFECTS OF FENOFIBRATE AND XUEZHIKANG ON HIGH‐FAT DIET‐INDUCED NON‐ALCOHOLIC FATTY LIVER DISEASEClinical and Experimental Pharmacology and Physiology, 2006
- Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in ratsJournal of Zhejiang University-SCIENCE B, 2006
- Non-alcoholic steatohepatitis: From cell biology to clinical practiceJournal of Hepatology, 2006
- Effect of Cordyceps Sinensis on Uncoupling Protein 2 in Experimental Rats with Nonalcoholic Fatty LiverJournal of Health Science, 2006
- Non-alcoholic steatohepatitis: physiopathological, clinical and therapeutic implicationsRevista Española de Enfermedades Digestivas, 2004
- Role of mitochondria in alcoholic liver injuryFree Radical Biology and Medicine, 2002
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998